Get the Stockscreener App
5.53
2.60%
0.14
After Hours:
5.50
-0.03
-0.54%
Anteris Technologies Global Corp stock is traded at $5.53, with a volume of 589.55K.
It is up +2.60% in the last 24 hours and down -11.80% over the past month.
Anteris Technologies Global Corp is a structural heart company focused on advancing cardiac care through science-driven innovations aimed at restoring heart valve patients to healthy function. Its key product, the DurAVR Transcatheter Heart Valve (THV), was designed in partnership with interventional cardiologists and cardiac surgeons to treat Aortic Stenosis, a potentially life-threatening condition caused by narrowing of the aortic valve. The balloon-expandable DurAVR THV is a biomimetic valve designed to mimic the performance of a healthy human aortic valve and replicate normal aortic blood flow. The company operates in United States, Germany, Australia, Switzerland, and Sweden, with the majority of its revenue generated from the United States.
See More
Previous Close:
$5.39
Open:
$5.49
24h Volume:
589.55K
Relative Volume:
0.55
Market Cap:
$537.69M
Revenue:
$1.91M
Net Income/Loss:
$-94.23M
P/E Ratio:
-2.1682
EPS:
-2.5505
Net Cash Flow:
$-79.76M
1W Performance:
-6.11%
1M Performance:
-11.80%
6M Performance:
+30.12%
1Y Performance:
+12.40%
1-Day Range:
$5.47
$5.67
1-Week Range:
$5.26
$6.04
52-Week Range:
$2.34
$6.9494
Anteris Technologies Global Corp Stock (AVR) Company Profile
Name
Anteris Technologies Global Corp
Sector
Industry
Phone
651-493-0606
Address
860 BLUE GENTIAN ROAD, EAGAN
Compare AVR vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AVR
Anteris Technologies Global Corp
|
5.53 | 524.08M | 1.91M | -94.23M | -79.76M | -2.5505 |
ISRG
Intuitive Surgical Inc
|
469.98 | 167.61B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
158.27 | 44.35B | 21.92B | 1.76B | 2.63B | 6.1223 |
ALC
Alcon Inc
|
75.26 | 36.19B | 10.40B | 980.00M | 1.61B | 1.9749 |
MDLN
Medline Inc
|
42.67 | 34.11B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
226.31 | 33.24B | 5.40B | 1.49B | 1.78B | 10.12 |
Anteris Technologies Global Corp Stock (AVR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-12-26 | Resumed | Cantor Fitzgerald | Overweight |
| Mar-11-26 | Initiated | Wells Fargo | Overweight |
| Jan-08-25 | Initiated | Lake Street | Buy |
| Jan-07-25 | Initiated | Barclays | Overweight |
| Jan-07-25 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-07-25 | Initiated | TD Cowen | Buy |
View All
Anteris Technologies Global Corp Stock (AVR) Latest News
Dividend Watch: Is Anteris Technologies Global Corp part of any ETF2026 Investor Takeaways & Low Volatility Stock Suggestions - baoquankhu1.vn
Trend Recap: Will Anteris Technologies Global Corp outperform small cap indexes2026 Performance Recap & Low Risk High Win Rate Picks - baoquankhu1.vn
[EFFECT] Anteris Technologies Global Corp. SEC Filing - Stock Titan
Barclays Remains a Buy on Anteris Technologies Global Corp. (AVR) - The Globe and Mail
Value Recap: Should I hold or sell Anteris Technologies Global Corp nowTrade Analysis Summary & Expert Verified Stock Movement Alerts - baoquankhu1.vn
Anteris Technologies (AVR) Receives Overweight Rating from Canto - GuruFocus
Anteris Technologies Global (NASDAQ:AVR) Now Covered by Analysts at Cantor Fitzgerald - MarketBeat
Anteris Technologies Global CEO Touts DurAVR Redesign, Durability Claims and TAVR Market Strategy - Yahoo Finance
Wells Fargo Initiates a Buy Rating on Anteris Technologies Global Corp. (AVR) - The Globe and Mail
Anteris Issues 78,740 Unquoted RSUs Under Employee Incentive Plan - TipRanks
Anteris Technologies Global (NASDAQ:AVR) Coverage Initiated by Analysts at Wells Fargo & Company - MarketBeat
Wells Fargo initiates Anteris Technologies stock at Overweight - Investing.com
Wells Fargo initiates Anteris Technologies stock at Overweight By Investing.com - Investing.com India
Total non-current liabilities of Anteris Technologies Global Corp. – NASDAQ:AVR - TradingView
Wall Street Analysts Are Neutral on Top Healthcare Picks - The Globe and Mail
Growth Value: Is Anteris Technologies Global Corp part of any ETF2026 Year in Review & Verified Technical Signals - baoquankhu1.vn
Highs Report: What is Anteris Technologies Global Corp.’s market position2026 Price Targets & Free Fast Gain Swing Trade Alerts - baoquankhu1.vn
Should I hold or sell Anteris Technologies Global Corp now2025 Macro Impact & Low Risk High Win Rate Stock Picks - baoquankhu1.vn
Anteris Technologies (AVR) CFO awarded 78,740 RSUs vesting 2027–2029 - Stock Titan
AVR Stock Pops Pre-Market: Medtronic Backs $200M Capital Raise To Fund Key Trial - Stocktwits
Cantor Fitzgerald Upgrades Anteris Technologies Global (NASDAQ:AVR) to Strong-Buy - MarketBeat
Anteris Technologies Global Highlights DurAVR TAVR Data, PARADIGM Pivotal Trial Plans at TD Cowen Conference - MarketBeat
Anteris adjusts CDI and common stock balances between ASX and Nasdaq - TipRanks
Retail Trends: Should I hold or sell Anteris Technologies Global Corp nowWatch List & Real-Time Buy Signal Notifications - baoquankhu1.vn
Anteris Options Lapse Trims Equity-Linked Securities Pool - TipRanks
Anteris Technologies grants Matthew McDonnell $500,000 RSU award - TradingView
AVRAnteris Reports 2025 Financial Results and Provides Corporate Update - mx.advfn.com
AVR Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Anteris net operating cash outflows hit USD 77.8M in FY 2025 - Medical Buyer
Anteris Reports 2025 Financial Results and Provides Corporate Update - Sahm
Anteris ramps up pivotal DurAVR trial on strong 2025 progress and fresh funding - TipRanks
Anteris widens 2025 loss as IPO funds fuel heart valve development - TipRanks
Anteris reports US$77.8m 2025 net operating cash outflow as PARADIGM trial gets underway - Yahoo Finance
Anteris Technologies Global Corp. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Anteris Technologies Global Corp. (AVR) Gets a Buy from Barclays - The Globe and Mail
Anteris Confirms Full Exercise of Underwriters’ Option and End of Stabilisation Period - TipRanks
Is Anteris Technologies Global Corp a speculative investmentJuly 2025 Setups & Technical Entry and Exit Tips - baoquankhu1.vn
Retail Trends: Is Unisys Corporation in a bullish channelRate Cut & Precise Swing Trade Alerts - baoquankhu1.vn
Shorts Report: What are analysts price targets for Blade Air Mobility IncEarnings Recap Summary & High Return Trade Guides - baoquankhu1.vn
Volume Summary: Can Anteris Technologies Global Corp beat the S P 5002025 Market Overview & Community Verified Swing Trade Signals - baoquankhu1.vn
Comparing Anteris Technologies Global (NASDAQ:AVR) & Sonova (OTCMKTS:SONVY) - Defense World
Anteris to Present at Healthcare Investor Conferences TD Cowen and Barclays - The Manila Times
Published on: 2026-02-23 14:17:27 - baoquankhu1.vn
Anteris Technologies Files Form S-1 to Enhance Market Flexibility - MSN
Earnings Miss: Is Anteris Technologies Global Corp still a buy after recent gainsJuly 2025 Institutional & Capital Efficient Trading Techniques - baoquankhu1.vn
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Can Anteris Technologies Global Corp. stock reach $100 price target2025 Top Gainers & Expert Curated Trade Ideas - mfd.ru
Short Interest in Anteris Technologies Global Corp. (NASDAQ:AVR) Expands By 39.7% - MarketBeat
Will Anteris Technologies Global Corp. stock continue upward momentumEarnings Growth Report & Reliable Breakout Stock Forecasts - mfd.ru
Price Action: Is Anteris Technologies Global Corp still a buy after recent gainsWeekly Investment Recap & Growth Oriented Trade Recommendations - baoquankhu1.vn
Is Anteris Technologies Global Corp. showing insider buyingJuly 2025 Chart Watch & Proven Capital Preservation Methods - mfd.ru
Anteris Technologies Global Corp Stock (AVR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.95%
0.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):